Spectrum of Genetic Mutations in Korean Pediatric Acute Lymphoblastic Leukemia.
Jae Won YooAri AhnJong-Mi LeeSuejung JoSeongkoo KimJae Wook LeeBin ChoYonggoo KimMyung-Shin KimNack-Gyun ChungPublished in: Journal of clinical medicine (2022)
The wide application of next-generation sequencing (NGS) technologies has led to the discovery of multiple genetic alterations in pediatric acute lymphoblastic leukemia (ALL). In this work, we aimed to investigate the mutational spectrum in pediatric ALL. We employed a St. Mary's customized NGS panel comprising 67 leukemia-related genes. Samples were collected from 139 pediatric ALL patients. Eighty-five patients (61.2%) harbored at least one mutation. In B-cell ALL, the RAS pathway is the most involved pathway, and the three most frequently mutated genes were NRAS (22.4%), KRAS (19.6%), and PTPN11 (8.4%). NRAS and PTPN11 were significantly associated with a high hyperdiploidy karyotype ( p = 0.018 and p < 0.001, respectively). In T-cell ALL, the three most frequently mutated genes were NOTCH1 (37.5%), FBXW7 (16.6%), and PTEN (6.2%). Several pairs of co-occurring mutations were found: NRAS with SETD , NRAS with PTPN11 in B-cell ALL ( p = 0.024 and p = 0.020, respectively), and NOTCH1 with FBXW7 in T-cell ALL ( p < 0.001). The most frequent newly emerged mutation in relapsed ALL was NT5C2 . We procured comprehensive genetic information regarding Korean pediatric ALL using NGS technology. Our findings strengthen the current knowledge of recurrent somatic mutations in pediatric ALL.
Keyphrases
- acute lymphoblastic leukemia
- wild type
- genome wide
- end stage renal disease
- ejection fraction
- newly diagnosed
- copy number
- acute myeloid leukemia
- cell proliferation
- prognostic factors
- healthcare
- peritoneal dialysis
- gene expression
- small molecule
- dna methylation
- high throughput
- patient reported outcomes
- diffuse large b cell lymphoma
- young adults
- social media